Stocktoria
Prestige Consumer Healthcare Inc. PBH
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2005-02-10
Prestige Consumer Healthcare Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% |
| Operating margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Net margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% |
| FCF margin | 22.6% | 21.4% | 21.3% | 19.7% | 23.0% |
| Return on assets | 5.4% | 6.3% | 6.3% | -2.5% | 5.6% |
| Return on equity | 10.1% | 11.7% | 12.6% | -5.7% | 13.0% |
| Debt / equity | 0.53× | 0.54× | 0.69× | 0.93× | 0.94× |
| Current ratio | 3.57 | 4.20 | 3.20 | 2.44 | 2.04 |
| Revenue growth | -4.3% | 1.1% | -0.2% | 3.8% | 15.2% |
Source: SEC EDGAR filings · CIK 0001295947 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.